Literature DB >> 7548334

Primary plasma cell leukemia with extensive dense osteosclerosis: complete remission following combination chemotherapy.

M C Kuo1, L Y Shih.   

Abstract

Diffuse osteosclerotic myeloma is very rare, and primary plasma cell leukemia with extensive osteosclerosis is even more rare. We describe a 71-year-old man who presented with severe anemia and dense widespread osteosclerosis similar to the X-ray finding of myelosclerosis. His peripheral blood showed 40% plasma cells. Bone marrow examination revealed heavy plasma cell infiltration with marked myelofibrosis and myelosclerosis. Protein electrophoresis and immunoelectrophoresis demonstrated an M-protein of IgG-lambda type. He was treated with cyclophosphamide, vincristine, and prednisolone for 10 months. A complete remission was obtained, with disappearance of M-protein and circulating plasma cells and normalization of complete blood counts, bone marrow picture, and biochemical parameters, as well as complete regression of myelofibrosis and osteosclerotic lesions. Unmaintained complete remission lasted for more than 1 year and he survived for more than 22 months. Our case indicated that one must include in the differential diagnosis of an osteosclerotic lesion the possibility of multiple myeloma, and that combination chemotherapy can induce a complete remission in this disease.

Entities:  

Mesh:

Year:  1995        PMID: 7548334     DOI: 10.1007/bf01702651

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  34 in total

1.  Plasma cell myeloma; a clinical, pathologic and roentgenologic review of 90 cases.

Authors:  C P CARSON; L V ACKERMAN; J D MALTBY
Journal:  Am J Clin Pathol       Date:  1955-08       Impact factor: 2.493

2.  Multiple myeloma with new bone formation.

Authors:  P KRAININ; C J D'ANGIO; A SMELIN
Journal:  Arch Intern Med (Chic)       Date:  1949-12

3.  Osteosclerotic myeloma and peripheral neuropathy. A case report.

Authors:  A Mangalik; A J Veliath
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

4.  Diffuse bone sclerosis in multiple myeloma.

Authors:  P D Clarisse; T W Staple
Journal:  Radiology       Date:  1971-05       Impact factor: 11.105

5.  Osteosclerotic myeloma with polyneuropathy.

Authors:  J B Reitan; E Pape; S D Fosså; O J Julsrud; O N Slettnes; O P Solheim
Journal:  Acta Med Scand       Date:  1980

6.  Plasma cell leukemia (PCL): A report on 15 patients.

Authors:  R K Woodruff; J S Malpas; A M Paxton; T A Lister
Journal:  Blood       Date:  1978-10       Impact factor: 22.113

7.  IgE multiple myeloma: a report of the third case.

Authors:  B G Fishkin; N Orloff; L E Scaduto; D T Borucki; H L Spiegelberg
Journal:  Blood       Date:  1972-03       Impact factor: 22.113

8.  IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alpha.

Authors:  N Yamagata; C Shimazaki; H Goto; T Hirata; E Ashihara; N Oku; T Inaba; N Fujita; M Nakagawa
Journal:  Am J Hematol       Date:  1994-03       Impact factor: 10.047

9.  High-dose intravenous melphalan for plasma-cell leukaemia and myeloma.

Authors:  T J McElwain; R L Powles
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

10.  Plasma cell dyscrasia with marrow fibrosis. Clinicopathologic syndrome.

Authors:  L Vandermolen; L Rice; E C Lynch
Journal:  Am J Med       Date:  1985-09       Impact factor: 4.965

View more
  1 in total

Review 1.  Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblast.

Authors:  Michaela R Reagan; Lucy Liaw; Clifford J Rosen; Irene M Ghobrial
Journal:  Bone       Date:  2015-02-26       Impact factor: 4.398

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.